1. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int 2000; 31(2):95-112.
2. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dent Assoc 1996; 127:1202-1213.
3. Garcia-Pola MJ, Garcia-Martin JM, Gonzales-Garcia M.Prevalence of oral lesions in the 6-year-old pediatric population of Oviedo (Spain). Med Oral 2002; 7(3):184-191.
4. Crivelli MR, Aguas S, Adler I, Quarracino C, Bazerque P. Influence of socioeconomic status on oral mucosa lesion prevalence in school children.Community Dent Oral Epidemiol 1988; 16:58-60.
5. Kleinman DV, Swango PA, Pindborg JJ. Epidemiology of oral mucosal lesions in United States school children: 1986-87. Community Dent Oral Epidemiol 1994; 22:243-253.
6. Greenberg MS, Pinto A. Etiology and Management of Recurrent Aphthous Stomatitis. Curr Infect Dis Rep. 2003; 5(3):194-198.
8. Ship, JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81(2):141-147.
9. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C. Recurrent aphthous stomatitis. Clin Dermatol. 2000; 18(5):569-578.
10. Buno IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998; 134(7):827-831.
11. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun. 2002; 3(5):302-305.
12. Sun A, Chia JS, Chiang CP. Increased proliferative response of peripheral blood mononuclear cells and T cells to Streptococcus mutans and glucosyltransferase D antigens in the exacerbation stage of recurrent aphthous ulcerations. J Formos Med Assoc. 2002; 101(8):560- 566.
13. Victoria JMN, Kalapothakis E, Silva JFC, and Gomez RS. Helicobacter pylori DNA in recurrent aphthous stomatitis. J Oral Pathol Med 2003; 32:219-223.
14. Birek C. Herpesvirus-induced diseases: oral manifestations and current treatment options. J Calif Dent Assoc 2000; 28(12):911-921.
15. Ghodratnama F, Wray D, Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med 1999; 28(1):12-15.
16. Stoopler ET, Sollectio TP. Recurrent aphthous stomatitis. Update for the general practitioner. N Y State Dent J.2003; 69(2):27-29.
22. Hirohata S, Kikuchi H. Behcet's disease. Arthritis Res Ther. 2003; 5(3):139-146.
23. Murat Ünal, Selman Vefa Yildirim, Muhsin Akbaba . A recurrent aphthous stomatitis case due to paediatric Behcet's disease. J Laryngol Otol 2001; 115(7):576-577.
24. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994; 3:535-559.
25. Scully C, MacFadyen EE, Campbell A. Orofacial manifestations in cyclic neutropenia. Br J Oral Surg 1982; 20:96-101.
26. Berlucchi M, Meini A, Plebani A, Bonvini MG, Lombardi D, Nicolai P. Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature. Ann Otol Rhinol Laryngol 2003; 112(4):365-369.
27. Wen-I Lee , Mei-Hui Yang , Kam-Fai Lee , Li-Chen Chen , Syh-Jae Lin , Kuo-Wei Yeh , Jing-Long Huang. PFAPA Syndrome (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis). Clin Rheumatol 1999; 18(3):207-213.
28. Leggott PJ. Oral manifestations manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992; 73:187-192.
29. Tilliss TS, McDowell JD. Differential diagnosis: is it herpes or aphthous? J Contemp Dent Pract 2002; 3(1):1-15.
31. Samonis G, Mantadakis E, Maraki S. Orofacial viral infections in the immunocompromised host. Oncol Rep 2000; 7(6):1389-1394.
32. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078-1080.
33. Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47(5):1125-1147.
34. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc 2003; 134(2):200-207.
35. Scully C, Porter SR. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. J Oral Pathol Med 1989; 18(1):21-27.
36. Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol 1992; 74(1):79-86.
37. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001; 68(3):201-206.
38. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001; 58(1):41-50
39. Orbak R, Cicek Y, Tezel A, Dogru Y. Effects of zinc treatment in patients with recurrent aphthous stomatitis. Dent Mater J 2003; 22(1):21-29.
40. Fontes V, Machet L, Huttenberger B, Lorette G, Vaillant L. Recurrent aphthous stomatitis: treatment with colchicine. Ann Dermatol Venereol. 2002; 129(12):1365-1369.
41. Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol 2003; 42(5):394-397.
42. Bessmertny O, Pham T. Thalidomide use in pediatric patients. Ann Pharmacother 2002; 36(3):521-525.
43. Calabrese L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000; 108(6):487-495.
44. Siegel MA. Strategies for management of commonly encountered oral mucosal disorders. J Calif Dent Assoc1999; 27(3):210-212.
Tekrarlayan aftöz stomatit TAS periyodik olarak oral kavitede ortaya çıkan ve kendiliğinden iyileşen tek veya çok sayıda ülserlerdir. Bu yüzeyel ve yuvarlak ülserler esas olarak keratinsiz mukozayı içeren enflamasyon şeklinde tanımlanabilir 1 .
Kaynakça
1. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int 2000; 31(2):95-112.
2. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dent Assoc 1996; 127:1202-1213.
3. Garcia-Pola MJ, Garcia-Martin JM, Gonzales-Garcia M.Prevalence of oral lesions in the 6-year-old pediatric population of Oviedo (Spain). Med Oral 2002; 7(3):184-191.
4. Crivelli MR, Aguas S, Adler I, Quarracino C, Bazerque P. Influence of socioeconomic status on oral mucosa lesion prevalence in school children.Community Dent Oral Epidemiol 1988; 16:58-60.
5. Kleinman DV, Swango PA, Pindborg JJ. Epidemiology of oral mucosal lesions in United States school children: 1986-87. Community Dent Oral Epidemiol 1994; 22:243-253.
6. Greenberg MS, Pinto A. Etiology and Management of Recurrent Aphthous Stomatitis. Curr Infect Dis Rep. 2003; 5(3):194-198.
8. Ship, JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81(2):141-147.
9. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C. Recurrent aphthous stomatitis. Clin Dermatol. 2000; 18(5):569-578.
10. Buno IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998; 134(7):827-831.
11. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun. 2002; 3(5):302-305.
12. Sun A, Chia JS, Chiang CP. Increased proliferative response of peripheral blood mononuclear cells and T cells to Streptococcus mutans and glucosyltransferase D antigens in the exacerbation stage of recurrent aphthous ulcerations. J Formos Med Assoc. 2002; 101(8):560- 566.
13. Victoria JMN, Kalapothakis E, Silva JFC, and Gomez RS. Helicobacter pylori DNA in recurrent aphthous stomatitis. J Oral Pathol Med 2003; 32:219-223.
14. Birek C. Herpesvirus-induced diseases: oral manifestations and current treatment options. J Calif Dent Assoc 2000; 28(12):911-921.
15. Ghodratnama F, Wray D, Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med 1999; 28(1):12-15.
16. Stoopler ET, Sollectio TP. Recurrent aphthous stomatitis. Update for the general practitioner. N Y State Dent J.2003; 69(2):27-29.
22. Hirohata S, Kikuchi H. Behcet's disease. Arthritis Res Ther. 2003; 5(3):139-146.
23. Murat Ünal, Selman Vefa Yildirim, Muhsin Akbaba . A recurrent aphthous stomatitis case due to paediatric Behcet's disease. J Laryngol Otol 2001; 115(7):576-577.
24. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994; 3:535-559.
25. Scully C, MacFadyen EE, Campbell A. Orofacial manifestations in cyclic neutropenia. Br J Oral Surg 1982; 20:96-101.
26. Berlucchi M, Meini A, Plebani A, Bonvini MG, Lombardi D, Nicolai P. Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature. Ann Otol Rhinol Laryngol 2003; 112(4):365-369.
27. Wen-I Lee , Mei-Hui Yang , Kam-Fai Lee , Li-Chen Chen , Syh-Jae Lin , Kuo-Wei Yeh , Jing-Long Huang. PFAPA Syndrome (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis). Clin Rheumatol 1999; 18(3):207-213.
28. Leggott PJ. Oral manifestations manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992; 73:187-192.
29. Tilliss TS, McDowell JD. Differential diagnosis: is it herpes or aphthous? J Contemp Dent Pract 2002; 3(1):1-15.
31. Samonis G, Mantadakis E, Maraki S. Orofacial viral infections in the immunocompromised host. Oncol Rep 2000; 7(6):1389-1394.
32. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078-1080.
33. Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47(5):1125-1147.
34. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc 2003; 134(2):200-207.
35. Scully C, Porter SR. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. J Oral Pathol Med 1989; 18(1):21-27.
36. Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol 1992; 74(1):79-86.
37. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001; 68(3):201-206.
38. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001; 58(1):41-50
39. Orbak R, Cicek Y, Tezel A, Dogru Y. Effects of zinc treatment in patients with recurrent aphthous stomatitis. Dent Mater J 2003; 22(1):21-29.
40. Fontes V, Machet L, Huttenberger B, Lorette G, Vaillant L. Recurrent aphthous stomatitis: treatment with colchicine. Ann Dermatol Venereol. 2002; 129(12):1365-1369.
41. Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol 2003; 42(5):394-397.
42. Bessmertny O, Pham T. Thalidomide use in pediatric patients. Ann Pharmacother 2002; 36(3):521-525.
43. Calabrese L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000; 108(6):487-495.
44. Siegel MA. Strategies for management of commonly encountered oral mucosal disorders. J Calif Dent Assoc1999; 27(3):210-212.